Professional Documents
Culture Documents
Yanagawa 2011
Yanagawa 2011
Case Report
Peripheral T-cell lymphoma arising from an intraglandular lymph
node in the parotid gland: A case report and literature review pin_2747 60..64
Naoki Yanagawa,1 Mitsumasa Osakabe,1 Hidekazu Furuse,2 Kunihiko Maeda3 and Gen Tamura1
Departments of 1Pathology and Laboratory Medicine and 2Otorhinolaryngology, Yamagata Prefectural Central
Hospital and 3Department of Nursing, Yamagata Prefectural University of Health Sciences, Yamagata, Japan
T/NK-cell lymphoma of the salivary gland is rare. A 58- T/NK-cell lymphomas are extremely rare.4,5 Herein, we
year-old man complained of a tumor mass in the left parotid describe the case of peripheral T-cell lymphoma, not other-
gland region and he was diagnosed to have a left parotid wise specified (PTCL-NOS) arising from an intraglandular
tumor. The tumor was subsequently resected, revealing a
lymph node in the parotid gland.
diffuse growth pattern of medium to large sized atypical
cells. The tumor was surrounded by fibrous connective
tissue in the form of a capsule, and those were positive for
CD3, CD4, CD5 and CD30, but negative for Bcl2, CD8, CD10,
CLINICAL SUMMARY
CD15, CD20, CD25, CD56, CD79a, CD246, EMA, granzyme B,
TdT and TIA-1. There was no molecular evidence of Epstein-
Barr virus (EBV) infection. It was diagnosed as peripheral A 58-year-old man presented at the Yamagata Prefectural
T-cell lymphoma (PTCL) arising from an intraglandular Central Hospital, Yamagata, Japan, after finding a tumor
lymph node in the parotid gland. In conclusion, Only 17 mass in the left parotid gland region. He had no past history
cases of primary T/NK-cell lymphoma of the salivary glands or family history of malignancy. Upon physical examination,
have been recorded until now, and the characteristics of the tumor mass was found to be 2.5 ¥ 2.5 cm in size. Swelling
these are not clear yet. Additional study is needed. of cervical lymph nodes was not detected. Laboratory data
revealed no significant abnormal findings. Serological analy-
Key words: intraglandular lymph node, salivary gland, T-cell sis of human T-cell leukemia virus type 1 antibodies was
lymphoma
negative. Computed tomography revealed a tumor 2.6 ¥
2.4 cm in size, located in the lower region of the left parotid
Malignant lymphomas arising from the salivary gland are
gland and slightly enhanced by contrast examination. Mag-
uncommon, accounting for approximately 5% of extranodal
netic resonance imaging revealed a tumor 2.7 ¥ 3.0 ¥ 2.5 cm
lymphomas, 2% of salivary gland neoplasms and 10% of
in size, with a smooth surface and no invasion of the sur-
malignant diseases of the salivary glands.1–3 The majority of
rounding tissue. T1-weighted sequences (Fig. 1a) indicated a
salivary gland lymphomas are of B-cell lineage such as low
relatively low-intensity tumor but T2-weighted sequences
grade B-cell lymphomas of mucosa-associated lymphoid
showed a high-intensity tumor (Fig. 1b) that was slightly
tissue, diffuse large B-cell lymphomas and follicular lympho-
enhanced by contrast examination (Fig. 1c). He was diag-
mas. A large proportion of such primary B-cell neoplasms
nosed to have a left parotid tumor and tumor resection was
have been shown to occur against a background of sia-
performed.
ladenitis associated with autoimmune disorders such as
Sjoegren’s syndrome. In contrast, primary salivary gland
Histopathological and immunohistochemical analyses but in some parts, the tumor extended over the capsule and
invaded the acinic cells and ducts of the parotid gland
Histopathological features of the tumor were assessed on the (Fig. 3b,c). Lymphatic vessels were seen in subcapsular
hematoxylin and eosin-stained sections of the formalin-fixed, sinus.
paraffin-embedded tissue specimens. Immunohistochemical
studies were performed on paraffin-embedded tissues using
the avidin-biotin peroxidase complex method. The primary Immunohistochemical findings
antibodies used were Bcl2 (124), CD3 (PS1), CD4 (1F6),
CD5 (4C7), CD8 (C8/144B), CD10 (56C6), CD30 (1G12), The medium to large sized atypical cells were positive for
CD56 (1B6), CD79a (JCB117), D2-40 (D2-40), EMA (E29) CD3, CD4, CD5 and CD30, but negative for Bcl2, CD8,
and TdT (SEN28) from Nichirei (Tokyo, Japan); CD15 (C3D- CD10, CD15, CD20, CD25, CD56, CD79a, CD246, EMA,
1), CD246 (ALK1) and granzyme B (GrB-7) from Dako Japan granzyme B, TdT and TIA-1 upon immunohistochemical
Inc. (Tokyo, Japan); CD25 (4C9) from Novocastra (New- staining (Fig. 4). EBV-RNA was not detected by ISH. From
castle, UK); and TIA-1 (TIA-1) from Abcam (Cambridge, UK). these findings, we diagnosed this tumor as PTCL-NOS.
The Epstein-Barr Virus (EBV) was detected by in situ hybrid-
ization (ISH).
DISCUSSION
ALCL, anaplastic large cell lymphoma; EBV, Epstein-Barr virus; N/A, data not available/mentioned in the original literature; NHL, non-Hodgkin’s lymphoma; NK, natural killer; PTCL-NOS, peripheral T-cell
>18 months, alive
5 months, died
8 months, died
6 weeks, died
node capsule and no lymph nodes, it can be defined as a true
Survival
N/A
N/A
N/A
N/A
parotid gland origin but rather a lymphoma originating from
an intraparotid lymph node because of the existence of a
capsule-like structure and remaining lymphatic vessels in
Chemoradiation
Chemoradiation
Chemoradiation
Chemoradiation
Chemoradiation
Chemotherapy
Chemotherapy
Chemotherapy
subcapsular sinus. However, as far as we examined with
Treatment
Resection
Resection
Resection
Resection
have not distinguished lymphoma of parotid gland origin from
N/A
N/A
N/A
N/A
N/A
N/A
N/A
lymphoma originating from the intraparotid lymph nodes, and
both have been reported as primary parotid gland lympho-
mas. In order to explore the development of lymphoma, it is
Negative
Negative
Negative
Negative
Negative
important to differentiate the former from the latter. Also the
Positive
Positive
Positive
Positive
Positive
Positive
Positive
EBV
N/A
N/A
N/A
Histopathological features of cases of T-cell lymphoma of the salivary glands reported in the literature (including our case)
T-NHL(PTCL-NOS)
T-NHL(PTCL-NOS)
T/NK angiocentric
T/NK angiocentric
T-NHL
T-NHL
T-NHL
T-NHL
ALCL
ALCL
ALCL
ATLL
ATLL
T/NK
Intra-salivary gland
Site of origin
ACKNOWLEDGMENTS
lymph node
lymph node
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Submandibular
Submandibular
Submandibular
Submandibular
Disease site
REFERENCES
Sublingual
Sublingual
Parotid
Parotid
Parotid
Parotid
Parotid
Parotid
Parotid
Parotid
Parotid
N/A
17–21.
N/A
N/A
N/A
N/A
Age
48
71
79
46
65
24
64
64
62
69
59
57
58
N/A
N/A
N/A
Sex
M
M
M
M
M
M
M
M
F
576–83.
Japanese
Japanese
Japanese
Japanese
Japanese
Chinese
Chinese
Chinese
Chinese
Chinese
Chinese
Chinese
Chinese
Chinese
N/A
MacLeod
Our case
Table 1
James
Miyagi
Chan
Hew
9 Chan JK, Tsang WY, Hui PK et al. T- and T/natural killer-cell of a case and review of the literature. J Clin Pathol 2002; 55:
lymphomas of the salivary gland: A clinicopathologic, immuno- 61–3.
histochemical and molecular study of six cases. Hum Pathol 12 Miyagi T, Nagasaki A, Taira T et al. Extranodal adult T-cell
1997; 28: 238–45. leukemia/lymphoma of the head and neck: A clinicopathological
10 Wen S, Mizugaki Y, Shinozaki F, Takada K. Epstein-Barr virus study of nine cases and a review of the literature. Leuk Lym-
(EBV) infection in salivary gland tumors: Lytic EBV infection in phoma 2009; 50: 187–95.
nonmalignant epithelial cells surrounded by EBV-positive 13 Schmid U, Helbron D, Lennert K. Primary malignant lymphomas
T-lymphoma cells. Virology 1997; 227: 484–7. localized in salivary glands. Histopathology 1982; 6: 673–87.
11 Hew WS, Carey FA, Kernohan NM, Heppleston AD, Jackson R,
Jarrett RF. Primary T cell lymphoma of salivary gland: A report